ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5DKazumasa Komura, Philip W. Kantoff, Kalyani Chadalavada et al.|Journal of Clinical Investigation|2018Cited by 79
<i>BRCA2</i>-<i>RB1</i> co-loss and ADT resistance in aggressive prostate cancer.Goutam Chakraborty, Philip W. Kantoff, Joshua Armenia et al.|Journal of Clinical Oncology|2018Cited by 1
Concurrent deletion of <i>BRCA2</i> and <i>RB1</i> and aggressive prostate cancer.Goutam Chakraborty, Philip W. Kantoff, Joshua Armenia et al.|Journal of Clinical Oncology|2018Cited by 0